Study of TRC102 in Combination With Pemetrexed in Cancer Patients
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This study is being performed to evaluate the safety and tolerability of TRC102 in
combination with Alimta. In addition to safety, this study will also evaluate
pharmacokinetics and tumor response.